Table 1 Main clinical and hematological characteristics of patients at diagnosis (n =75)

Age, years

66 (32–83)

 < 65

34

 ≥ 65

41

Gender

 Male

52 (69)

 Female

23 (31)

Hemoglobin level, g/L

91 (57–136)

 < 100

50

 ≥ 100

25

Leukocyte count, × 10⁹/L

2.9 (0.8–108)

 < 4

47

 > 4 and < 11

14

 ≥ 11

14

Platelet count, × 10⁹/L

68 (5–536)

 < 100

48

 ≥ 100

27

Neutrophil count, × 10⁹/L

1.23 (0.09–13.55)

 < 0.8

27

 ≥ 0.8

47

 No data

1

Blasts in PB, %

0 (0–74)

 < 5

55

 ≥ 5

20

Blasts in BM, %

15 (0–92)

 < 20

49

 ≥ 20

26

Cytogenetic

 Normal karyotype

28

 Abnormal karyotype

45

 Uninformative CC

2

Cytogenetic category (IPSS-R)

 Very good

1

 Good

30

 Intermediate

20

 Poor

6

 Very poor

16

 Uninformative CC

2

IPSS risk group (only MDS patients: 49)

 Intermediate-1

6

 Intermediate-2

23

 High

19

 No data

1

IPSS-R risk group (only MDS patients: 49)

 Low

1

 Intermediate

9

 High

16

 Very high

21

 No data

2

Treatment

 AZA

38

 Other treatment (ICE plus AZA and/or ASCT)

37